Seres Therapeutics Publishes New Data In Nature Medicine And Journal Of Infectious Diseases Supporting VOWST Mechanism And Broader Live Biotherapeutics Platform

Benzinga · 4d ago
  • Data demonstrate clinical translation of VOWST mechanisms of action in both first and multiply recurrent CDI patients
  • Seres MbTx® platform provides high-resolution functional biological understanding of live biotherapeutics and supports the advancement of Seres' portfolio, including Phase 2-ready lead candidate SER-155